Drug Use
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Kimia TherapeuticsCA - Berkeley
2 programsAcyclovir 200 MGN/A1 trial
Furosemide 40 mgN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Kimia TherapeuticsAcyclovir 200 MG
Kimia TherapeuticsFurosemide 40 mg
Clinical Trials (2)
Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject
Start: Feb 2020Est. completion: Apr 2020
N/ACompleted
Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers
Start: Dec 2019Est. completion: Jan 2020
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space